Caredx Inc (CDNA): Next-Year EPS Estimate 33.80%
As of 2026-04-29, Caredx Inc (CDNA) has a next-year EPS growth estimate of 33.80%.
On 2026-04-29, analyst consensus for CDNA's next-year EPS growth shifted from 54.24% to 33.80% — a negative change of 20.44 percentage points. Current-year growth is projected at 42.82%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 33.80%
- EPS growth this year
- 42.82%
- EPS next quarter (est)
- $0.20
- Last price
- $21.99
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-04-29 | 33.80% | 42.82% | $0.20 | $21.99 |
| 2026-04-28 | 54.24% | 21.36% | $0.13 | $21.91 |
| 2026-04-20 | 4359.79% | 98.33% | -$0.05 | $21.29 |
| 2026-04-19 | 4359.79% | 98.33% | -$0.05 | $21.42 |
| 2026-04-16 | 4359.79% | 98.33% | -$0.05 | $22.42 |
| 2026-04-15 | 515.61% | 82.92% | -$0.06 | $17.57 |
| 2026-04-14 | 515.61% | 82.92% | -$0.06 | $17.63 |
| 2026-04-13 | 515.61% | 82.92% | -$0.06 | $16.83 |
| 2026-04-12 | 515.61% | 82.92% | -$0.06 | $16.05 |
| 2026-04-10 | 515.61% | 82.92% | -$0.06 | $16.25 |
| 2026-04-09 | 515.61% | 82.92% | -$0.06 | $16.69 |
| 2026-04-08 | 515.61% | N/A | -$0.06 | $17.92 |
| 2026-04-07 | 515.61% | N/A | -$0.06 | $17.67 |
| 2026-04-06 | 515.61% | N/A | -$0.06 | $17.67 |
| 2026-04-05 | 515.61% | N/A | -$0.06 | $18.31 |
| 2026-04-03 | 515.61% | N/A | -$0.06 | $17.67 |
| 2026-04-02 | 515.61% | N/A | -$0.06 | $17.67 |
| 2026-04-01 | 515.61% | N/A | -$0.06 | $17.67 |
| 2026-04-01 | 515.61% | N/A | N/A | $17.87 |
| 2026-04-01 | 515.61% | N/A | N/A | $17.87 |
| 2026-04-01 | 515.61% | N/A | N/A | $17.87 |
| 2026-03-31 | 515.61% | N/A | N/A | $17.36 |
| 2026-03-31 | 515.61% | N/A | N/A | $17.36 |
| 2026-03-31 | 515.61% | N/A | N/A | $17.36 |
| 2026-03-30 | 515.61% | N/A | N/A | $16.43 |
| 2026-03-30 | 515.61% | N/A | N/A | $16.43 |
| 2026-03-30 | 515.61% | N/A | N/A | $16.43 |
| 2026-03-29 | 515.61% | N/A | N/A | $16.78 |
| 2026-03-29 | 515.61% | N/A | N/A | $16.78 |
| 2026-03-27 | 515.61% | N/A | N/A | $16.78 |
Recent News
- CareDx: Q1 Earnings SnapshotAssociated Press
- CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance TestingBusiness Wire
- CareDx Announces First Quarter 2026 Financial ResultsBusiness Wire
- Why Diagnostics Names CareDx And QuidelOrtho Just DivergedInvestor's Business Daily
- CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial ResultsBusiness Wire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Caredx Inc's next-year EPS growth estimate?▾
As of 2026-04-29, Caredx Inc (CDNA) has a next-year EPS growth estimate of 33.80%, based on analyst consensus.
When was the latest EPS estimate revision for CDNA?▾
The most recent revision occurred on 2026-04-29, when analysts adjusted the next-year EPS growth estimate from 54.24% to 33.80%.
What sector and industry does Caredx Inc belong to?▾
Caredx Inc operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CDNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Caredx Inc (CDNA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports